McKinstry Nancy's Form 4 filing
Abbott Laboratories (ABT) · filed Feb 25, 2022
- Accession no.
- 0001415889-22-001883
- Filed
- Feb 25, 2022
- Trade date
- Feb 24, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $187.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McKinstry NancyCIK 0001294731 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2022 | Common shares without par value | MOption exerciseAcquired | +6,280 | $29.84 | +$187,395.2 | 33,419 | Direct | |
| Feb 24, 2022 | Common shares without par value | SSaleDisposed | −1,614 | $116.43 | −$187,918.02 | 31,805 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2022 | Common Shares | MOption exerciseDisposed | −6,280 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.